Blood/EMB Levine culture media recalled due to Listeria contamination
Remel, Inc. is recalling Blood/EMB Levine 100/PK culture media due to potential Listeria monocytogenes surface and subsurface contamination. The product was distributed nationwide across the US.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall involving high-risk pathogen Listeria monocytogenes without reported illness or injury. Per the rubric, high-risk pathogens like Listeria without reported illness warrant a High severity score of 3.
Plain-English summary
Remel, Inc. is recalling Blood/EMB Levine 100/PK culture media (Product Number R02041), distributed nationwide across the United States. Approximately 750 units are affected.
The products may contain surface and subsurface contamination of Listeria monocytogenes.
Healthcare facilities and laboratories that have received this product should not use the affected lot (Lot Number 274194). Contact Remel, Inc. for further guidance and instructions regarding this recall.
The recalled product
- Product
- Blood/EMB, Levine 100/PK, Product Number R02041
- Manufacturer
- Remel, Inc
- Hazard
- listeria
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- UDI-DI: 848838003684
- Lot Numbers: 274194
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- SevereMedline spinal anesthesia kits recalled for bupivacaine quality issues
FDA (Devices) · 2026-06-03
- SevereMedline Spinal Trays Recalled Due to Quality and Efficacy Concerns
FDA (Devices) · 2026-06-03
- SevereMedline Spinal Block Kits Recalled for Data Integrity and Efficacy Issues
FDA (Devices) · 2026-06-03
- SevereAbiomed Automated Impella Controller recalled for motor control and pump failure risks
FDA (Devices) · 2026-06-03
- HighGE APEXPRO and CARESCAPE Telemetry Systems Risk Loss of Patient Monitoring
FDA (Devices) · 2026-06-03